Nucleophosmin Mutation Could be a Prognostic Factor in AML

Amr El-Sayed Ahmed Yousef;

Abstract


Nucleophosmin (NPM1) exon-12 gene mutations have recently been described in patients with acute myeloid leukemia especially those with normal cytogenetics. It is restricted to the compartment of myeloid cells since NPM1 mutations do not target lymphoid ce


Other data

Title Nucleophosmin Mutation Could be a Prognostic Factor in AML
Authors Amr El-Sayed Ahmed Yousef
Keywords Nucleophosmin Mutation Could be a Prognostic Factor in AML
Issue Date 2010
Description 
Nucleophosmin (NPM1) exon-12 gene mutations have recently been described in patients with acute myeloid leukemia especially those with normal cytogenetics. It is restricted to the compartment of myeloid cells since NPM1 mutations do not target lymphoid ce

Attached Files

File SizeFormat
96616r2880.pdf169.56 kBAdobe PDFView/Open
Recommend this item

Similar Items from Core Recommender Database

Google ScholarTM

Check



Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.